Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Baxter

Showing results (501-510 of 652) with videos related to

Pageof 66
Sort By:
Human Reproduction (Oxford, England)|June 1, 1993
Supplementary growth hormone treatment of women with poor ovarian response to exogenous gonadotrophins: changes in serum and follicular fluid insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3)Z H Huang, R C Baxter, S M Hughes, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2010
Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary womenVita Birzniece, Udo Meinhardt, James Gibney, et al.
Journal of Cell Communication and Signaling|October 31, 2014
CCN2 requires TGF-β signalling to regulate CCAAT/enhancer binding proteins and inhibit fat cell differentiationWilliam W C Song, Susan V McLennan, Charmaine Tam, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 9, 2005
Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trialAndre Sevette, Ross C Smith, Alireza Aslani, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1996
Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markersH de Boer, G J Blok, C Popp-Snijders, et al.
Clinical Nephrology|January 1, 1986
Renal tubular transport of cyclosporine A (CSA) and associated changes in renal functionR J Caterson, G G Duggin, L Critchley, et al.
The Journal of Endocrinology|June 6, 1998
The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitusT D Cheetham, J M Holly, R C Baxter, et al.
Kidney International|September 18, 1997
Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic childrenD Haffner, B Tönshoff, W F Blum, et al.
Gastroenterology|May 16, 2006
Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technologyChristopher J Scarlett, Ross C Smith, Alex Saxby, et al.
Cornea|January 1, 1989
ELISA HIV testing and viral culture in the screening of corneal tissue for transplant from medical examiner casesE Heck, C Petty, A Palestine, et al.
Pageof 66

Showing results (501-510 of 652) with videos related to

Sort By:
Pageof 66
Human Reproduction (Oxford, England)|June 1, 1993
Supplementary growth hormone treatment of women with poor ovarian response to exogenous gonadotrophins: changes in serum and follicular fluid insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3)Z H Huang, R C Baxter, S M Hughes, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2010
Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary womenVita Birzniece, Udo Meinhardt, James Gibney, et al.
Journal of Cell Communication and Signaling|October 31, 2014
CCN2 requires TGF-β signalling to regulate CCAAT/enhancer binding proteins and inhibit fat cell differentiationWilliam W C Song, Susan V McLennan, Charmaine Tam, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 9, 2005
Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trialAndre Sevette, Ross C Smith, Alireza Aslani, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1996
Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markersH de Boer, G J Blok, C Popp-Snijders, et al.
Clinical Nephrology|January 1, 1986
Renal tubular transport of cyclosporine A (CSA) and associated changes in renal functionR J Caterson, G G Duggin, L Critchley, et al.
The Journal of Endocrinology|June 6, 1998
The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitusT D Cheetham, J M Holly, R C Baxter, et al.
Kidney International|September 18, 1997
Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic childrenD Haffner, B Tönshoff, W F Blum, et al.
Gastroenterology|May 16, 2006
Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technologyChristopher J Scarlett, Ross C Smith, Alex Saxby, et al.
Cornea|January 1, 1989
ELISA HIV testing and viral culture in the screening of corneal tissue for transplant from medical examiner casesE Heck, C Petty, A Palestine, et al.
Pageof 66